Rockefeller Capital Management’s Vicarious Surgical RBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$636 Hold
884
﹤0.01% 4544
2025
Q4
$1.92K Buy
884
+468
+113% +$1.9K ﹤0.01% 4332
2025
Q3
$2.29K Buy
+416
New +$3.18K ﹤0.01% 4061
2023
Q1
Sell
-183
Closed -$11K 3471
2022
Q4
$11K Hold
183
﹤0.01% 3049
2022
Q3
$18K Hold
183
﹤0.01% 2827
2022
Q2
$16K Sell
183
-167
-48% -$20.4K ﹤0.01% 2870
2022
Q1
$53K Buy
350
+50
+17% +$9.3K ﹤0.01% 2281
2021
Q4
$95K Buy
300
+167
+126% +$58.9K ﹤0.01% 1963
2021
Q3
$59K Buy
+133
New +$42.1K ﹤0.01% 2065

Other funds holding RBOT

Rockefeller Capital Management's RBOT Position: Q1 2026 in Review

Rockefeller Capital Management held its Vicarious Surgical (RBOT) position steady in Q1 2026 at 884 shares worth $636. The position accounts for ﹤0.01% of the portfolio, ranked #4544.

Rockefeller Capital Management first reported a position in RBOT in Q3 2021 and has held it in 9 quarters since. The position peaked at $95K in Q4 2021. 8 funds tracked by Wall St. Rank hold RBOT as of Q1 2026.

  • Rockefeller Capital Management held 884 shares of Vicarious Surgical worth $636 as of Q1 2026.
  • Rockefeller Capital Management left its Vicarious Surgical share count unchanged in Q1 2026.
  • Vicarious Surgical made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4544 holding.
  • Rockefeller Capital Management first reported a position in Vicarious Surgical in Q3 2021 and has held it in 9 quarters since.
  • Rockefeller Capital Management's Vicarious Surgical position peaked at $95K in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Vicarious Surgical as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.